FAXAGE: Fasting And Exercise To Slow Aging In Humans
FAXAGE
FAXAGE: A Randomized, Controlled Clinical Trial Of Fasting And Exercise To Slow Aging In Humans
1 other identifier
interventional
240
1 country
1
Brief Summary
FAXAge is a randomized controlled trial investigating the effects of fasting and exercise on human aging. 240 participants over the age of 65 will be divided into 4 groups - an exercise group, a fasting group, a combined exercise and fasting group and a control group. The intervention will last for one year, and tests of biomarkers of aging will be performed at baseline, after 3 months, 6 months and at the end of the intervention. A reference group of participants over the age of 20 equally distributed by age and sex will be used to train an algorithm for determination of biological age. The study will include both physical, molecular and digital biomarkers including DNA-methylation, VO2max, body composition and face- and voice-age. The main outcome of the project is DNA-methylation age at week 52. Secondary outcomes are the rest of the tested biomarkers at week 52. It is hypothesised that the intervention groups will have similar superior benefits after the 52 weeks of intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2042
January 28, 2026
September 1, 2025
1.9 years
September 23, 2025
January 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
DNA-methylation age
Changes in predicted biological age from baseline based on DNA-methylation from isolated peripheral blood mononucleated cells after 52 weeks of intervention
From enrollment until end of intervention at 52 weeks
Study Arms (4)
TRF
EXPERIMENTALEXE
EXPERIMENTALFAX
EXPERIMENTALCON
NO INTERVENTIONInterventions
Supervised strength training 2x/week + self-administered cardio training 2x/week.
Time-restricted feeding in a 16/8 regimen - 16 hours of fast and 8 hours of eating per day.
Strength and cardio exercise 2x/week each combined with time-restricted feeding in a 16/8 regimen.
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Aged \>20 years
- In good general health meaning maximally 1 well-managed chronic disease
- Non-smoker.
You may not qualify if:
- Inability or unwillingness to adhere to the TRF regiment
- Inability or unwillingness to perform the prescribed physical exercise
- Treatment with other investigational drug or intervention within 1 year
- \>1 hour of systematic strenuous exercise or strength training a week
- Current time-restricted eating habits
- Severe or dysregulated medical disease (i.e. active cancer, uncontrolled diabetes, severe pulmonary or heart disease)
- \>1 well-managed chronic disease
- Smoker
- Use of systemic glucocorticoids, androgens or antiandrogens.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Copenhagen
Copenhagen, Copenhagen N, 2200, Denmark
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2025
First Posted
October 3, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
August 30, 2027
Study Completion (Estimated)
August 30, 2042
Last Updated
January 28, 2026
Record last verified: 2025-09